| Study Period | 2019 - 2032 |
| Market Size in 2025 | USD 6.5 Billion |
| Market Size in 2026 | USD 6.8 Billion |
| Market Size by 2032 | USD 9.1 Billion |
| Projected CAGR | 5% |
| Largest Province | Al-Riyadh |
| Fastest-Growing Region Province | Eastern Province |
| Market Structure | Semi-Consolidated |
Explore the market potential with our data-driven report
The Saudi Arabian medical devices market size will be an estimated USD 6.5 billion for 2025, and it will grow by 5.0% during 2026–2032, to reach USD 9.1 billion by 2032.
The market growth is primarily driven by the increasing prevalence of chronic diseases, substantial government healthcare investments under Vision 2030, and the rising demand for advanced medical technologies across the Kingdom.
The Saudi Arabian government has allocated USD 69 billion (SAR 260 billion) for health and social development in 2025, maintaining consistent investment levels from the previous year. This substantial healthcare expenditure underscores the government's commitment to transforming the healthcare sector as part of Vision 2030 initiatives. Saudi Arabia accounts for 60% of the Gulf Cooperation Council countries' healthcare expenditure, positioning the Kingdom as the largest healthcare market in the region.
The market is witnessing robust growth in monitoring devices and diagnostic imaging segments, driven by the increasing burden of non-communicable diseases. Saudi Arabia imports nearly 90% of its medical device requirements from other countries, primarily from the U.S. and Europe, due to limited local manufacturing capacity. This heavy import dependency presents opportunities for international manufacturers while highlighting the government's focus on developing domestic production capabilities through localization initiatives and public–private partnerships.
The diagnostic devices category holds the largest market share in 2025, driven by increasing demand for early disease detection and the growing prevalence of chronic conditions requiring regular monitoring. The segment benefits from government initiatives prioritizing preventive healthcare and expanding diagnostic infrastructure across the Kingdom's health clusters.
The therapeutic devices category will have the highest CAGR during the forecast period, fueled by rising demand for cardiovascular and diabetes management devices. The aging population and increasing chronic disease burden drive demand for advanced therapeutic solutions, including insulin delivery systems, cardiac devices, and respiratory equipment. Government investments in specialized treatment centers and the focus on reducing healthcare-associated mortality support this segment's rapid expansion.
The products analyzed in this report are:
The cardiology category holds the largest market share in 2025, driven by the high prevalence of cardiovascular diseases as the leading cause of mortality in the Kingdom. The cardiology segment's dominance reflects the substantial disease burden, with ischemic heart disease ranking highest among the top 10 causes of death in Saudi Arabia. The prevalence of cardiovascular risk factors, including hypertension, obesity, and diabetes, drives consistent demand for cardiac monitoring devices, diagnostic equipment, and therapeutic interventions.
The orthopedics category will have the highest CAGR of 5.2%, due to the rising incidence of musculoskeletal disorders, increasing trauma and accident cases, and expanding demand for joint replacement and rehabilitation solutions. Additionally, advancements in orthopedic implant technology and growing investments in healthcare infrastructure further accelerate the segment’s growth across the Kingdom.
The clinical subspecialities analyzed in this report are:
The hospitals & ambulatory surgical centers category holds the largest market share, of 70%, in 2025, supported by substantial government investments in healthcare infrastructure expansion. The development of specialized medical centers and the privatization of healthcare facilities under Vision 2030 drive demand for advanced medical devices across hospital settings.
The home healthcare settings category will have the highest CAGR, of 5.4%, reflecting the shift toward patient-centric care and remote monitoring solutions. The increasing adoption of telemedicine and wearable devices, combined with the aging population's preference for home-based care, accelerates growth in this segment.
The end users analyzed in this report are:
The direct tender/institutional sales category holds the largest market share, of 75%, in 2025, reflecting the government's centralized procurement system through the National Unified Company for Medical Supplies. NUPCO is responsible for centralized government procurement of pharmaceuticals, medical equipment, and supplies for all public healthcare facilities, which account for over 60% of the country's healthcare expenditure.
The dominance of institutional sales stems from Saudi Arabia's healthcare system structure, where government hospitals and healthcare facilities represent the primary purchasers of medical devices. NUPCO collects requirements from all government agencies in the healthcare sector and issues tenders to meet those demands, resulting in a centralized distribution framework that prioritizes bulk procurement agreements and approved suppliers.
The e-commerce category will have the highest CAGR, of 5.3%, driven by digital transformation initiatives and the increasing adoption of remote healthcare solutions. The growth of telemedicine and home healthcare services accelerates demand for medical devices through digital channels, particularly for monitoring equipment, diagnostic tools, and consumable medical supplies. The expansion of e-commerce in medical devices aligns with Vision 2030's digital health objectives and the Kingdom's broader e-commerce growth strategy. Healthcare providers increasingly utilize online platforms for the procurement of routine medical supplies, while patients access home healthcare devices through digital marketplaces, supporting the shift toward patient-centric care delivery models.
The distribution channels analyzed in this report are:
Drive strategic growth with comprehensive market analysis
Al-Riyadh holds the largest market share, of 35%, in 2025, driven by its position as the Kingdom's capital and the concentration of major healthcare institutions and government facilities. The province hosts King Faisal Specialist Hospital and Research Centre, Riyadh Military Hospital, and numerous specialized medical centers, creating substantial demand for advanced medical technologies and diagnostic equipment.
The province benefits from significant healthcare infrastructure investments, including the establishment of medical cities and the relocation of multinational healthcare companies' regional headquarters to Riyadh. GE Healthcare announced the relocation of its regional headquarters to Riyadh in October 2023, while Johnson & Johnson began direct operations in February 2024, highlighting the capital's strategic importance for medical device companies.
The province's robust healthcare spending and the presence of specialized treatment centers for cardiology, oncology, and diabetes care drive demand for monitoring devices, diagnostic imaging equipment, and therapeutic devices. Government initiatives to expand emergency services and increase weekly surgeries from 2,000 to 8,400 procedures further boost medical device adoption across the distribution network.
Eastern Province will have the highest CAGR, of 5.1%, reflecting rapid healthcare infrastructure development and increasing industrial healthcare needs. The province's strategic location and oil industry presence drive demand for occupational health devices and emergency medical equipment across industrial facilities and healthcare centers.
The province houses major healthcare facilities, including King Fahad Hospital and multiple specialized centers, serving the industrial workforce and growing urban population. The development of new medical cities and the expansion of healthcare services to support Vision 2030's economic diversification initiatives create opportunities for medical device manufacturers across diagnostic, therapeutic, and monitoring segments.
The provinces of the market are as follows:
The market is semi-consolidated due to the presence of several dominant multinational corporations that maintain their positions through direct operations, joint ventures, and strategic investments in healthcare infrastructure, alongside a growing number of localized manufacturing and distribution partnerships. Recent strategic activities include equipment partnerships and facility expansions. These partnerships, often involving high-value medical technologies, signal a growing concentration of operational and technological capabilities among a select group of players. The competitive landscape is evolving as international companies establish manufacturing capabilities and strengthen their presence through localization strategies. The government's emphasis on developing domestic production capacity and reducing import dependency creates opportunities for companies investing in local manufacturing and technology transfer initiatives.
Want a report tailored exactly to your business need?
Request CustomizationLeading companies across industries trust us to deliver data-driven insights and innovative solutions for their most critical decisions. From data-driven strategies to actionable insights, we empower the decision-makers who shape industries and define the future. From Fortune 500 companies to innovative startups, we are proud to partner with organisations that drive progress in their industries.
Working with P&S Intelligence and their team was an absolute pleasure – their awareness of timelines and commitment to value greatly contributed to our project's success. Eagerly anticipating future collaborations.
McKinsey & Company
India
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws
Customize the Report to Align with Your Business Objectives
Request the Free Sample Pages